menu search

IPHA / Innate Pharma to Participate in Upcoming Investor Conferences

Innate Pharma to Participate in Upcoming Investor Conferences
MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming conferences: American Society for Clinical Oncology (ASCO) 2023 Annual Meeting Event Date: June 2-5, Chicago (USA) Jefferies Healthcare Conference 2023 Event Date: June 7-9, New-York (USA) Goldman Sachs 44th Annual Global Healthcare Conference Event Date: June 12-15,. Read More
Posted: May 23 2023, 01:00
Author Name: Business Wire
Views: 110860

IPHA News  

Innate Pharma Announces Its Participation to Upcoming Investor Conferences

By Business Wire
October 27, 2023

Innate Pharma Announces Its Participation to Upcoming Investor Conferences

MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal

Innate Pharma Announces Its Participation to Upcoming Investor Conferences and Conference Call for First Half 2023 Business Update

By Business Wire
August 29, 2023

Innate Pharma Announces Its Participation to Upcoming Investor Conferences and Conference Call for First Half 2023 Business Update

MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal

Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides at the International Conference on Malignant Lymphoma

By Business Wire
June 12, 2023

Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides at the International Conference on Malignant Lymphoma

MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal

Innate (IPHA) Gains as Blood Cancer Drug Gets Fast Track Tag

By Zacks Investment Research
June 9, 2023

Innate (IPHA) Gains as Blood Cancer Drug Gets Fast Track Tag

Innate (IPHA) and Sanofi's SAR'579 / IPH6101 get Fast Track Designation in the United States for the treatment of hematological malignancies. more_horizontal

Why Shares of Innate Pharma Jumped Thursday

By The Motley Fool
June 8, 2023

Why Shares of Innate Pharma Jumped Thursday

A therapy Innate Pharma and Sanofi are developing was granted Fast Track Designation by the FDA. Innate Pharma has enough cash to fund operations into more_horizontal

Innate Pharma to Participate in Upcoming Investor Conferences

By Business Wire
May 23, 2023

Innate Pharma to Participate in Upcoming Investor Conferences

MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal

Innate Pharma to Present IPH6501 Preclinical Data at The EHA 2023 Congress

By Business Wire
May 15, 2023

Innate Pharma to Present IPH6501 Preclinical Data at The EHA 2023 Congress

MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal

Innate Pharma SA (IPHA) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 13, 2023

Innate Pharma SA (IPHA) Q1 2023 Earnings Call Transcript

Innate Pharma SA (NASDAQ:IPHA ) Q1 2023 Earnings Conference Call May 10, 2023 8:00 AM ET Company Participants Henry Wheeler - VP, IR & Communication M more_horizontal


Search within

Pages Search Results: